Rodger Novak

2018

In 2018, Rodger Novak earned a total compensation of $645.6K as President at CRISPR Therapeutics AG, a 81% decrease compared to previous year.

Compensation breakdown

Salary$498,836
Other$146,736
Total$645,572

Novak received $498.8K in salary, accounting for 77% of the total pay in 2018.

Novak also received $146.7K in other compensation.

Rankings

In 2018, Rodger Novak's compensation ranked 11,016th out of 14,244 executives tracked by ExecPay. In other words, Novak earned more than 22.7% of executives.

ClassificationRankingPercentile
All
11,016
out of 14,244
23rd
Division
Manufacturing
4,440
out of 5,765
23rd
Major group
Chemicals And Allied Products
1,683
out of 2,128
21st
Industry group
Drugs
1,429
out of 1,817
21st
Industry
Biological Products, Except Diagnostic Substances
275
out of 339
19th
Source: SEC filing on April 30, 2019.

Novak's colleagues

We found four more compensation records of executives who worked with Rodger Novak at CRISPR Therapeutics AG in 2018.

2018

Samarth Kulkarni

CRISPR Therapeutics AG

Chief Executive Officer

2018

Tony Ho

CRISPR Therapeutics AG

EVP, Research and Development

2018

James Kasinger

CRISPR Therapeutics AG

General Counsel

2018

Michael Tomsicek

CRISPR Therapeutics AG

Chief Financial Officer

News

You may also like